Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thavarak Ouk

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
British Journal of Pharmacology|February 9, 2005
Pharmacological neutropenia prevents endothelial dysfunction but not smooth muscle functions impairment induced by middle cerebral artery occlusionOlivier Pétrault, Thavarak Ouk, Sophie Gautier, et al.
Biomedicines|July 29, 2025
High-Fat-Diet-Induced Metabolic Disorders: An Original Cause for Neurovascular Uncoupling Through the Imbalance of Glutamatergic PathwaysManon Haas, Maud Petrault, Patrick Gele, et al.
Fundamental & Clinical Pharmacology|October 1, 2016
Neither nefopam nor acetaminophen can be used as postoperative analgesics in a rat model of ischemic strokeMaud Pétrault, Sophie Gautier, Vincent Bérézowski, et al.
The Annals of Thoracic Surgery|July 26, 2006
Changes in cerebral vascular reactivity occur early during cardiopulmonary bypass in the ratThomas Modine, Richard Azzaoui, Thavarak Ouk, et al.
Vascular Pharmacology|January 19, 2016
Lipid-lowering drugs prevent neurovascular and cognitive consequences of cardiopulmonary bypassThavarak Ouk, Gilles Amr, Richard Azzaoui, et al.
Nutrients|July 18, 2017
Effects of Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) on Fetal Pulmonary Circulation: An Experimental Study in Fetal LambsDyuti Sharma, Estelle Aubry, Thavarak Ouk, et al.
Pharmacology & Therapeutics|September 22, 2018
Neutrophils in tPA-induced hemorrhagic transformations: Main culprit, accomplice or innocent bystander?Thavarak Ouk, Camille Potey, Ilaria Maestrini, et al.
Current Drug Targets|March 22, 2013
PPARs: a potential target for a disease-modifying strategy in strokeThavarak Ouk, Camille Potey, Sophie Gautier, et al.
Fundamental & Clinical Pharmacology|May 25, 2013
PPARα is involved in the multitargeted effects of a pretreatment with atorvastatin in experimental strokeThavarak Ouk, Camille Potey, Maud Laprais, et al.
Journal of Neuroinflammation|June 3, 2014
Impact of the neutrophil response to granulocyte colony-stimulating factor on the risk of hemorrhage when used in combination with tissue plasminogen activator during the acute phase of experimental strokeSophie Gautier, Thavarak Ouk, Madjid Tagzirt, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
British Journal of Pharmacology|February 9, 2005
Pharmacological neutropenia prevents endothelial dysfunction but not smooth muscle functions impairment induced by middle cerebral artery occlusionOlivier Pétrault, Thavarak Ouk, Sophie Gautier, et al.
Biomedicines|July 29, 2025
High-Fat-Diet-Induced Metabolic Disorders: An Original Cause for Neurovascular Uncoupling Through the Imbalance of Glutamatergic PathwaysManon Haas, Maud Petrault, Patrick Gele, et al.
Fundamental & Clinical Pharmacology|October 1, 2016
Neither nefopam nor acetaminophen can be used as postoperative analgesics in a rat model of ischemic strokeMaud Pétrault, Sophie Gautier, Vincent Bérézowski, et al.
The Annals of Thoracic Surgery|July 26, 2006
Changes in cerebral vascular reactivity occur early during cardiopulmonary bypass in the ratThomas Modine, Richard Azzaoui, Thavarak Ouk, et al.
Vascular Pharmacology|January 19, 2016
Lipid-lowering drugs prevent neurovascular and cognitive consequences of cardiopulmonary bypassThavarak Ouk, Gilles Amr, Richard Azzaoui, et al.
Nutrients|July 18, 2017
Effects of Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) on Fetal Pulmonary Circulation: An Experimental Study in Fetal LambsDyuti Sharma, Estelle Aubry, Thavarak Ouk, et al.
Pharmacology & Therapeutics|September 22, 2018
Neutrophils in tPA-induced hemorrhagic transformations: Main culprit, accomplice or innocent bystander?Thavarak Ouk, Camille Potey, Ilaria Maestrini, et al.
Current Drug Targets|March 22, 2013
PPARs: a potential target for a disease-modifying strategy in strokeThavarak Ouk, Camille Potey, Sophie Gautier, et al.
Fundamental & Clinical Pharmacology|May 25, 2013
PPARα is involved in the multitargeted effects of a pretreatment with atorvastatin in experimental strokeThavarak Ouk, Camille Potey, Maud Laprais, et al.
Journal of Neuroinflammation|June 3, 2014
Impact of the neutrophil response to granulocyte colony-stimulating factor on the risk of hemorrhage when used in combination with tissue plasminogen activator during the acute phase of experimental strokeSophie Gautier, Thavarak Ouk, Madjid Tagzirt, et al.
Pageof 3